ID
18454
Description
Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2; ODM derived from: https://clinicaltrials.gov/show/NCT00085839
Link
https://clinicaltrials.gov/show/NCT00085839
Keywords
Versions (1)
- 11/6/16 11/6/16 -
Uploaded on
November 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Small Cell Lung Cancer NCT00085839
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Abnormality of the gastrointestinal tract
Data type
boolean
Alias
- UMLS CUI [1]
- C4023588
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Description
Epidermal growth factor receptor inhibitor
Data type
boolean
Alias
- UMLS CUI [1]
- C1443775
Description
Malignant Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
Metastatic malignant neoplasm to brain Uncontrolled
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0205318
Description
Abnormality of the cornea Severe
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1855670
- UMLS CUI [1,2]
- C0205082
Description
Heart Disease Significant
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C0750502
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00085839
- StudyEvent: Eligibility
C3258246 (UMLS CUI [2])
C0205210 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0205483 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,2])